Prot #DCC-2618-03-002: A Phase 3, Interventional, Randomized, Multicenter, Open-Label Study of DCC-2618 vs Sunitinib in Patients with Advanced Gastrointestinal Stromal Tumors after Treatment with Imatinib

Project: Research project

Project Details

StatusActive
Effective start/end date4/22/194/22/22

Funding

  • Deciphera Pharmaceuticals, LLC (Prot #DCC-2618-03-002)